Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

22.6K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
22.6K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi-omics characterization of developing forebrain organoids unravels the dynamic molecular events of Rett syndrome pathogenesis.

Journal of neurodevelopmental disorders·2026
Same author

Generation and characterization of three human induced pluripotent stem cell lines (UGENTi005, UGENTi006 and UGENTi007) from patients with autosomal dominant adult-onset maculopathy due to RPE65 variant c.1555G>A, p.(E519K).

Stem cell research·2025
Same author

Targeting oncogenic fusion-driven NUT carcinoma with CRISPR-Cas9 genome editing.

Molecular therapy. Oncology·2025
Same author

Generation of induced pluripotent stem cell lines from three LGMD R1 patients carrying CAPN3 hypomorphic intronic variant c.1746-20C > G.

Stem cell research·2025
Same author

Vaccine-induced T cell receptor T cell therapy targeting a glioblastoma stemness antigen.

Nature communications·2025
Same author

Involvement of extracellular vesicle microRNA clusters in developing healthy and Rett syndrome brain organoids.

Cellular and molecular life sciences : CMLS·2024

Related Experiment Video

Updated: Jun 25, 2025

Efficient Generation Human Induced Pluripotent Stem Cells from Human Somatic Cells with Sendai-virus
09:43

Efficient Generation Human Induced Pluripotent Stem Cells from Human Somatic Cells with Sendai-virus

Published on: April 23, 2014

23.2K

A Simple Nonviral Method to Generate Human Induced Pluripotent Stem Cells Using SMAR DNA Vectors.

Anna Hartley1,2, Luisa Burger1,2, Cornelia L Wincek1

  • 1DNA Vector Laboratory, German Cancer Research Center, 69120 Heidelberg, Germany.

Genes
|May 25, 2024
PubMed
Summary

This study demonstrates generating induced pluripotent stem cells (iPSCs) using nonviral SMAR DNA vectors without the oncogenic EBNA-1 system. This novel method offers a safer alternative for producing high-quality iPSCs for biomedical research.

Keywords:
S/MARSMAR DNA vectoriPSCnonviralreprogrammingstem cells

More Related Videos

Generation of Human Induced Pluripotent Stem Cells from Peripheral Blood Using the STEMCCA Lentiviral Vector
12:03

Generation of Human Induced Pluripotent Stem Cells from Peripheral Blood Using the STEMCCA Lentiviral Vector

Published on: October 31, 2012

26.6K
Generation of Induced Pluripotent Stem Cells by Reprogramming Human Fibroblasts with the Stemgent Human TF Lentivirus Set
12:10

Generation of Induced Pluripotent Stem Cells by Reprogramming Human Fibroblasts with the Stemgent Human TF Lentivirus Set

Published on: December 8, 2009

29.9K

Related Experiment Videos

Last Updated: Jun 25, 2025

Efficient Generation Human Induced Pluripotent Stem Cells from Human Somatic Cells with Sendai-virus
09:43

Efficient Generation Human Induced Pluripotent Stem Cells from Human Somatic Cells with Sendai-virus

Published on: April 23, 2014

23.2K
Generation of Human Induced Pluripotent Stem Cells from Peripheral Blood Using the STEMCCA Lentiviral Vector
12:03

Generation of Human Induced Pluripotent Stem Cells from Peripheral Blood Using the STEMCCA Lentiviral Vector

Published on: October 31, 2012

26.6K
Generation of Induced Pluripotent Stem Cells by Reprogramming Human Fibroblasts with the Stemgent Human TF Lentivirus Set
12:10

Generation of Induced Pluripotent Stem Cells by Reprogramming Human Fibroblasts with the Stemgent Human TF Lentivirus Set

Published on: December 8, 2009

29.9K

Area of Science:

  • Biomedical Research
  • Stem Cell Biology
  • Genetic Engineering

Background:

  • Induced pluripotent stem cells (iPSCs) are crucial for research but traditional generation methods using viruses pose safety risks like insertional mutagenesis and oncogenesis.
  • Nonviral vectors are safer but often struggle to achieve the necessary expression levels and duration for efficient reprogramming.
  • Current nonviral methods frequently rely on the Epstein-Barr nuclear antigen 1 (EBNA-1) system, which carries potential oncogenic risks.

Purpose of the Study:

  • To investigate the efficacy of nonviral SMAR DNA vectors for reprogramming human fibroblasts into iPSCs.
  • To determine if these vectors can achieve sufficient expression for pluripotency induction without relying on the EBNA-1 system.
  • To develop an optimized protocol for generating high-quality iPSCs using this nonviral approach.

Main Methods:

  • Utilized nonviral SMAR DNA vectors for the delivery of reprogramming factors to human fibroblasts.
  • Optimized a reprogramming protocol specifically for the SMAR DNA vector system.
  • Assessed the pluripotency and cellular function of the generated iPSCs.

Main Results:

  • Successfully generated induced pluripotent stem cells (iPSCs) from human fibroblasts using nonviral SMAR DNA vectors.
  • Demonstrated that these vectors can provide sufficient expression for pluripotency induction without the need for the EBNA-1 system.
  • Produced high-quality iPSCs with pluripotency and cellular functions comparable to those generated by viral or EBNA-1 based methods.

Conclusions:

  • Nonviral SMAR DNA vectors offer a viable and safer alternative for iPSC generation, eliminating the need for viral vectors or the EBNA-1 system.
  • This optimized protocol facilitates the production of clinically relevant iPSCs with robust pluripotency and functionality.
  • The findings pave the way for safer and more efficient applications of iPSCs in regenerative medicine and disease modeling.